858114-78-0 Usage
Uses
Used in Pharmaceutical Industry:
(2E)-3-(2,6-Difluoro-4-Methoxyphenyl)-2-propenoic Acid Ethyl Ester is used as a key intermediate in the synthesis of D446215, a compound with potential pharmaceutical applications. Its unique structure and properties make it a valuable component in the development of new drugs and therapeutic agents.
Used in Chemical Synthesis:
(2E)-3-(2,6-Difluoro-4-Methoxyphenyl)-2-propenoic Acid Ethyl Ester is used as a versatile building block in the synthesis of various organic compounds. Its reactivity and functional groups allow for further chemical modifications and the creation of new molecules with diverse applications in various industries.
Used in Research and Development:
(2E)-3-(2,6-Difluoro-4-Methoxyphenyl)-2-propenoic Acid Ethyl Ester is utilized in research and development settings to explore its potential applications and properties. Scientists and researchers investigate its chemical behavior, reactivity, and interactions with other compounds to gain insights into its possible uses and benefits.
Check Digit Verification of cas no
The CAS Registry Mumber 858114-78-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,8,1,1 and 4 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 858114-78:
(8*8)+(7*5)+(6*8)+(5*1)+(4*1)+(3*4)+(2*7)+(1*8)=190
190 % 10 = 0
So 858114-78-0 is a valid CAS Registry Number.
858114-78-0Relevant articles and documents
PHENYLPROPANOIC ACID DERIVATIVES
-
Page/Page column 40, (2008/06/13)
The present invention provides a novel compound having a GPR40 receptor function modulating action, which is useful as an insulin secretagogue, a drug for the prophylaxis or treatment of diabetes and the like. A compound represented by the formula (I) wherein each symbol is as defined in the specification, a salt thereof and a prodrug thereof have unexpectedly superior GPR40 receptor agonist activity and also show superior properties as a pharmaceutical product, such as stability and the like. Thus, they can be safe and useful drugs for the prophylaxis or treatment of GPR40 receptor related conditions or diseases in mammals.
ALKOXYPHENYLPROPANOIC ACID DERIVATIVES
-
Page/Page column 33, (2008/06/13)
The present invention aims at provision of a novel compound having a GPR40 receptor function modulating action, which is useful as an insulin secretagogue, an agent for the prophylaxis or treatment of diabetes and the like. The compound represented by the formula: wherein each symbol is as defined in the description, a salt thereof, and a prodrug thereof of the present invention unexpectedly have a superior GPR40 receptor agonistic activity and superior properties as pharmaceutical products such as stability and the like, and can be safe and useful pharmaceutical agents as agents for the prophylaxis or treatment of GPR40 receptor-related pathology or diseases in mammals.
